_version_ 1818850345344827392
author Felix Chu
Michael Harbell
Amy Manning-Bog
Alexander Scholz
Ngan Nguyen
Norman Greenberg
William Robinson
Daniel Emerling
Tito Serafini
Wei Cao
Yvonne Leung
Nikhil Vad
Anne Ye
Daniel Santos
Cathrin Czupalla
John Vivian
Carlene Williams
Judevin Sapugay
Shaun Lippow
Chantia Carroll
Lance Kates
Benjamin Haugen
Gary Bolton
Mark Armanini
Iraz Aydin
Mark Whidden
Mauricio Velasco-Delgado
Erin Wechsler
author_facet Felix Chu
Michael Harbell
Amy Manning-Bog
Alexander Scholz
Ngan Nguyen
Norman Greenberg
William Robinson
Daniel Emerling
Tito Serafini
Wei Cao
Yvonne Leung
Nikhil Vad
Anne Ye
Daniel Santos
Cathrin Czupalla
John Vivian
Carlene Williams
Judevin Sapugay
Shaun Lippow
Chantia Carroll
Lance Kates
Benjamin Haugen
Gary Bolton
Mark Armanini
Iraz Aydin
Mark Whidden
Mauricio Velasco-Delgado
Erin Wechsler
author_sort Felix Chu
collection DOAJ
first_indexed 2024-12-19T06:47:39Z
format Article
id doaj.art-d68b61ac36ac49e5b4d60c03de821131
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-19T06:47:39Z
publishDate 2020-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-d68b61ac36ac49e5b4d60c03de8211312022-12-21T20:31:52ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0689689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of ActionFelix Chu0Michael Harbell1Amy Manning-Bog2Alexander Scholz3Ngan Nguyen4Norman Greenberg5William Robinson6Daniel Emerling7Tito Serafini8Wei Cao9Yvonne Leung10Nikhil Vad11Anne Ye12Daniel Santos13Cathrin Czupalla14John Vivian15Carlene Williams16Judevin Sapugay17Shaun Lippow18Chantia Carroll19Lance Kates20Benjamin Haugen21Gary Bolton22Mark Armanini23Iraz Aydin24Mark Whidden25Mauricio Velasco-Delgado26Erin Wechsler27Atreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USAAtreca, Inc, South San Francisco, CA, USA
spellingShingle Felix Chu
Michael Harbell
Amy Manning-Bog
Alexander Scholz
Ngan Nguyen
Norman Greenberg
William Robinson
Daniel Emerling
Tito Serafini
Wei Cao
Yvonne Leung
Nikhil Vad
Anne Ye
Daniel Santos
Cathrin Czupalla
John Vivian
Carlene Williams
Judevin Sapugay
Shaun Lippow
Chantia Carroll
Lance Kates
Benjamin Haugen
Gary Bolton
Mark Armanini
Iraz Aydin
Mark Whidden
Mauricio Velasco-Delgado
Erin Wechsler
689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
Journal for ImmunoTherapy of Cancer
title 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
title_full 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
title_fullStr 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
title_full_unstemmed 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
title_short 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
title_sort 689 atrc 101 drives potent single agent activity in mouse syngeneic tumor models via a novel cellular mechanism of action
work_keys_str_mv AT felixchu 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT michaelharbell 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT amymanningbog 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT alexanderscholz 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT ngannguyen 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT normangreenberg 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT williamrobinson 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT danielemerling 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT titoserafini 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT weicao 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT yvonneleung 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT nikhilvad 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT anneye 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT danielsantos 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT cathrinczupalla 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT johnvivian 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT carlenewilliams 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT judevinsapugay 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT shaunlippow 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT chantiacarroll 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT lancekates 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT benjaminhaugen 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT garybolton 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT markarmanini 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT irazaydin 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT markwhidden 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT mauriciovelascodelgado 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction
AT erinwechsler 689atrc101drivespotentsingleagentactivityinmousesyngeneictumormodelsviaanovelcellularmechanismofaction